Iproniazid in Angina Pectoris

Iproniazid in angina pectoris; a double-blind study.

There has beell considerable recent interest ill the treatment of anginla pectoris witlh iproniazid. In this paper the results of a careful double-blind study of its effect are evaluated. I PRONIAZID (Marsilid) ,@ a hydrazine derivative of isonicotinic acid, originally employed with success as an antituberculosis agent, was later replaced by isoniazid, to avoid central nervous system stimulatio...

Nonconventional therapeutic modalities in refractory angina pectoris

    Abstract   Despite sophisticated conventional medical treatment and the continued development   and improvement of coronary revascularization modalities in recent years, a significant   number of patients still suffer from refractory angina pectoris and cannot be successfully   managed. Advances in therapeutic options have led to an increase in the average of life   expectancy even in such ...

C-REACTIVE PROTEIN RESPONSE IN ANGINA PECTORIS

C-reactive protein (CRP) response was studied in 44 patients with acute angina pectoris admitted to the coronary care unit. 71 % of patients with acute myocardial infarction (MI)had positive CRP test while 73% of patients presumed to have unstable angina pectoris had negative CRP test. This test can be helpful in differentiating between acute MI and unstable angina pectoris.

Angina pectoris.

Anticardiolipin and Antiphospholipid Antibodies in Iraqi Patients with Angina Pectoris